Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications: low out-of-specification dissolution test results observed.
| Brand name | ALPRAZOLAM |
| Generic name | ALPRAZOLAM |
| Active ingredient(s) | ALPRAZOLAM |
| Distributed by / for | Greenstone LLC, Peapack, NJ 07977 |
| NDC | 59762-0068-1 |
| Full product label | alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977, NDC 59762-0068-1. |
| Recalling firm | Viatris Inc |
| Distribution | Product was distributed nationwide in the USA |
| Quantity | 6,789 bottles |
| Recall initiated | 2022-04-28 |
| Report date | 2022-05-11 |
| Recall completed | 2023-06-21 |
| Recall number | D-0844-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Canonsburg PA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗